Biostage, now known as Harvard Apparatus Regenerative Technology (HRGN), is a clinical-stage biotechnology company based in Holliston, Massachusetts. They specialize in using a patient's own stem cells grown on a hollow tubular scaffold to regenerate damaged organ tissue caused by cancer, trauma, birth defects, or other diseases.
With a focus on addressing unmet medical needs, HRGN is actively working to develop innovative solutions for conditions such as esophageal atresia, a life-threatening congenital defect affecting approximately 1 in 4,000 babies in the US alone. Through their groundbreaking technology, HRGN aims to provide effective treatment options for patients in need of organ regeneration.
Generated from the website